NYSE:PHG - Koninklijke Philips Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 9
  • Breakdown:
  • 1 Sell Ratings
  • 2 Hold Ratings
  • 6 Buy Ratings
  • 0 Strong Buy Ratings
$50.01
▼ -0.65 (-1.28%)

This chart shows the closing price for PHG by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Koninklijke Philips Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for PHG and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for PHG

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 9 analysts offering 12 month price targets for Koninklijke Philips in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $50.01.

This chart shows the closing price for PHG for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 9 polled investment analysts is to buy stock in Koninklijke Philips. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/1/2020
  • 0 strong buy ratings
  • 8 buy ratings
  • 1 hold ratings
  • 0 sell ratings
3/31/2020
  • 0 strong buy ratings
  • 9 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/29/2020
  • 0 strong buy ratings
  • 8 buy ratings
  • 1 hold ratings
  • 1 sell ratings
9/27/2020
  • 0 strong buy ratings
  • 9 buy ratings
  • 1 hold ratings
  • 1 sell ratings
12/26/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 2 hold ratings
  • 1 sell ratings
3/26/2021
  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 1 sell ratings
5/25/2021
  • 0 strong buy ratings
  • 6 buy ratings
  • 2 hold ratings
  • 1 sell ratings
6/24/2021

Latest Recommendations

  • 0 strong buy ratings
  • 6 buy ratings
  • 2 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/21/2021HSBCDowngradeBuy ➝ HoldLow
4/29/2021Berenberg BankReiterated RatingBuyLow
4/28/2021Credit Suisse GroupReiterated RatingNeutralLow
4/27/2021UBS GroupReiterated RatingBuyLow
3/23/2021BarclaysReiterated RatingOverweightMedium
3/18/2021JPMorgan Chase & Co.UpgradeNeutral ➝ OverweightMedium
1/26/2021Credit Suisse GroupReiterated RatingNeutralHigh
1/26/2021JPMorgan Chase & Co.Reiterated RatingNeutralHigh
1/26/2021UBS GroupReiterated RatingBuyHigh
1/20/2021Berenberg BankReiterated RatingBuyLow
1/19/2021JPMorgan Chase & Co.Reiterated RatingNeutralLow
11/12/2020Berenberg BankReiterated RatingBuyLow
10/29/2020Morgan StanleyReiterated RatingOverweightLow
10/21/2020Deutsche Bank AktiengesellschaftReiterated RatingBuyLow
10/20/2020UBS GroupReiterated RatingBuyLow
10/20/2020JPMorgan Chase & Co.Reiterated RatingNeutralLow
10/2/2020UBS GroupReiterated RatingBuyLow
9/23/2020JPMorgan Chase & Co.Reiterated RatingNeutralLow
9/23/2020BarclaysReiterated RatingOverweightLow
9/3/2020JPMorgan Chase & Co.Reiterated RatingNeutralHigh
9/1/2020UBS GroupReiterated RatingBuyMedium
8/27/2020Societe GeneraleDowngradeSellLow
7/28/2020Societe GeneraleInitiated CoverageBuyMedium
7/21/2020JPMorgan Chase & Co.Reiterated RatingNeutralLow
7/9/2020Morgan StanleyReiterated RatingOverweightLow
6/22/2020BarclaysReiterated RatingOverweightLow
4/22/2020Morgan StanleyReiterated RatingOverweightLow
4/21/2020JPMorgan Chase & Co.Reiterated RatingNeutralMedium
4/19/2020Kepler Capital MarketsReiterated RatingHoldHigh
4/7/2020JPMorgan Chase & Co.Reiterated RatingNeutralLow
3/23/2020DZ BankReiterated RatingHold ➝ BuyHigh
3/23/2020UBS GroupReiterated RatingBuyLow
3/10/2020Kepler Capital MarketsReiterated RatingHoldMedium
2/10/2020UBS GroupReiterated RatingBuyLow
1/21/2020Roth CapitalReiterated RatingBuyMedium
1/13/2020Bank of AmericaBoost Price TargetBuy$45.00 ➝ $51.00Low
12/6/2019Morgan StanleyUpgradeEqual Weight ➝ OverweightMedium
10/28/2019Berenberg BankReiterated RatingBuyMedium
10/7/2019Berenberg BankReiterated RatingBuyLow
8/29/2019JPMorgan Chase & Co.Reiterated RatingNeutralLow
7/30/2019CitigroupInitiated CoverageBuy ➝ BuyLow
10/2/2018Credit Suisse GroupDowngradeOutperform ➝ NeutralLow
9/18/2018Exane BNP ParibasUpgradeNeutral ➝ OutperformLow
9/17/2018BNP ParibasUpgradeHold ➝ BuyLow
9/13/2018Sanford C. BernsteinInitiated CoverageOutperformLow
4/17/2018Deutsche Bank AktiengesellschaftUpgradeHold ➝ BuyLow
2/12/2018Berenberg BankUpgradeHold ➝ BuyLow
11/9/2017JPMorgan Chase & Co.DowngradeOverweight ➝ NeutralN/A
10/24/2017CitigroupReiterated RatingBuyN/A
10/16/2017BNP ParibasDowngradeOutperform ➝ NeutralN/A
7/24/2017JPMorgan Chase & Co.Reiterated RatingBuyLow
7/3/2017Canaccord GenuityReiterated RatingBuy$37.00Low
6/21/2017NatixisDowngradeBuy ➝ NeutralLow
6/20/2017Deutsche Bank AktiengesellschaftDowngradeBuy ➝ HoldMedium
4/25/2017Societe GeneraleDowngradeBuy ➝ HoldLow
3/21/2017Deutsche Bank AktiengesellschaftReiterated RatingBuyLow
2/7/2017Berenberg BankInitiated CoverageHoldN/A
1/26/2017CitigroupReiterated RatingBuyN/A
12/12/2016Morgan StanleyDowngradeOverweight ➝ Equal WeightN/A
11/23/2016CitigroupInitiated CoverageBuyN/A
10/24/2016Credit Suisse GroupReiterated RatingBuy$30.00N/A
8/10/2016UBS GroupUpgradeNeutral ➝ BuyN/A
(Data available from 6/24/2016 forward)
Koninklijke Philips logo
Koninklijke Philips N.V. operates as a health technology company in North America, Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. It provides magnetic resonance imaging, computed tomography, advanced molecular imaging, diagnostic X-ray, and imaging components as well as integrated clinical solutions; integrated interventional systems, including interventional diagnostic and therapeutic devices; imaging products focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services. The company also offers monitoring and analytics solutions; sleep and respiratory care solutions; emergency care and resuscitation, and patient management solutions; data, analytics, and actionable workflow solutions; and connected care informatics solutions. In addition, it provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding and digital parental solutions; male grooming and beauty products and solutions; and kitchen appliances, home care, and garment care products, as well as coffee machines. Koninklijke Philips N.V. has a partnership with openDoctor to deliver an integrated radiology patient engagement platform that leverages openDoctor's real-time online appointment scheduling services as part of its patient management solution; and a strategic collaboration with Ibex Medical Analytics Ltd. to jointly promote the digital pathology and AI solutions to hospitals, health networks, and pathology laboratories worldwide. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.
Read More

Today's Range

Now: $50.01
Low: $49.93
High: $50.49

50 Day Range

MA: $56.49
Low: $50.01
High: $61.10

52 Week Range

Now: $50.01
Low: $44.24
High: $61.23

Volume

532,989 shs

Average Volume

565,748 shs

Market Capitalization

$45.27 billion

P/E Ratio

32.90

Dividend Yield

1.74%

Beta

0.83

Frequently Asked Questions

What sell-side analysts currently cover shares of Koninklijke Philips?

The following equities research analysts have issued research reports on Koninklijke Philips in the last year: Barclays PLC, Berenberg Bank, Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, HSBC Holdings plc, JPMorgan Chase & Co., Morgan Stanley, Societe Generale, TheStreet, UBS Group AG, and Zacks Investment Research.
View the latest analyst ratings for PHG.

What is the current price target for Koninklijke Philips?

0 Wall Street analysts have set twelve-month price targets for Koninklijke Philips in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Koninklijke Philips in the next year.
View the latest price targets for PHG.

What is the current consensus analyst rating for Koninklijke Philips?

Koninklijke Philips currently has 1 sell rating, 2 hold ratings and 6 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe PHG will outperform the market and that investors should add to their positions of Koninklijke Philips.
View the latest ratings for PHG.

What other companies compete with Koninklijke Philips?

How do I contact Koninklijke Philips' investor relations team?

Koninklijke Philips' physical mailing address is PHILIPS CENTER AMSTELPLEIN 2, AMSTERDAM P7, 1096 BC. The technology company's listed phone number is 31-20-597-7777 and its investor relations email address is [email protected] The official website for Koninklijke Philips is www.philips.com.